East of England Dementia Trials Network
A Member Site of the UK Dementia Trials Network (UKDTN)

Capabilities directory

Operational depth, ready to connect.

Explore the populations, people, facilities and methods available for dementia trials across the region.

Start feasibility

Clinical populations

Memory clinics, early-onset cohorts, rare dementias, and diverse urban and rural reach.

  • Established NHS memory-service pathways
  • Early-onset and genetically defined cohorts
  • Urban, rural and coastal communities
  • PPIE-supported recruitment planning

Early-phase experimental medicine

Phase I, Ib and II capability, including first-in-human studies.

  • Early-phase protocol delivery
  • Intensive pharmacokinetic schedules
  • First-in-human governance
  • Specialist medical cover

Advanced therapeutics

Intrathecal delivery, antisense oligonucleotides, gene-silencing and novel mAbs.

  • Intrathecal administration pathways
  • ASO and gene-silencing expertise
  • Novel monoclonal antibodies
  • Complex safety monitoring

Advanced imaging

3T and 7T MRI, amyloid and tau PET, and total-body PET at Wolfson Brain Imaging Centre.

  • 3T and ultra-high-field 7T MRI
  • Amyloid and tau PET
  • Total-body PET capability
  • Quantitative image analysis

Fluid biomarkers & laboratories

CSF, plasma p-tau217, NfL and high-throughput assays.

  • CSF collection and processing
  • Plasma p-tau217 and NfL
  • High-throughput assay platforms
  • Sample handling and biobanking

Clinical Research Facilities

Dedicated CRFs and experienced dementia research nursing teams.

  • Purpose-designed participant facilities
  • Specialist research nursing
  • Complex visit delivery
  • Extended observation capacity

Cambridge Clinical Trials Unit

Neuro CTU expertise spanning design, statistics, operations and regulation.

  • Protocol and statistical design
  • Trial management and data systems
  • Regulatory and quality support
  • Neuroscience methodology

Specialist investigators & PPIE

Connected investigators and participant partners shaping relevant, accessible studies.

  • Regional principal investigator network
  • Specialist dementia expertise
  • Public and patient involvement
  • Community-informed study design

Tell us what your protocol needs. We’ll map the regional response.

Request capability matching